| RS1592880489 |
PTS
|
Health Risk |
Conflicting classifications of pathogenicity |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS1592882265 |
UBE3B
|
Health Risk |
Pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS1592890905 |
MED13L
|
Health Risk |
Likely pathogenic |
— |
| RS1592891007 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1592897526 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1592898255 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1592913789 |
HPD
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS1592915896 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1592919048 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Autism spectrum disorder |
| RS1592923871 |
MED13L
|
Health Risk |
Likely pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1592939069 |
MED13L
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1592940794 |
MED13L
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1592941857 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1592944816 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592945394 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592945607 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592947508 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592947538 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592947563 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592947582 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592949408 |
PAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Phenylketonuria, Phenylketonuria |
| RS1592952179 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592952183 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592953143 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592953902 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1592954413 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592961381 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592972259 |
UBE3B
|
Health Risk |
Likely pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS1592977444 |
SETD1B
|
Health Risk |
Likely pathogenic |
Epilepsy, Epilepsy |
| RS1592978629 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978725 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978760 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978816 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978901 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978950 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978986 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592978992 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592979013 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592988488 |
SETD1B
|
Health Risk |
Pathogenic |
— |
| RS1592991145 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592991176 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592991184 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592991196 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592991220 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592991243 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1592996077 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1592997663 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS1592998207 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1593005589 |
DDX54
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental delay, Seizure |
| RS1593008134 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1593015642 |
MVK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperimmunoglobulin D with periodic fever, Hyperimmunoglobulin D with periodic fever |
| RS1593021917 |
MVK
|
Health Risk |
Pathogenic |
Hyperimmunoglobulin D with periodic fever, Hyperimmunoglobulin D with periodic fever |
| RS1593023809 |
RPS26
|
Health Risk |
Likely pathogenic |
Anemia, Pure red-cell aplasia |
| RS1593026935 |
MVK
|
Health Risk |
Likely pathogenic |
Hyperimmunoglobulin D with periodic fever, Hyperimmunoglobulin D with periodic fever |
| RS1593037878 |
RAD9B
|
Health Risk |
Likely pathogenic |
Neural tube defect, Neural tube defect |
| RS1593039493 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1593054210 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1593055101 |
ALX1
|
Health Risk |
Pathogenic |
Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome, Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome |
| RS1593058338 |
HNF1A
|
Health Risk |
Likely pathogenic/Likely risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1593058831 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS1593058932 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1593060859 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS1593060890 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 3 |
| RS1593060912 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1593060966 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1593070775 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1593072345 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1593073030 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1593073279 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593076474 |
SYT1
|
Health Risk |
Likely pathogenic |
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome, Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome |
| RS1593076635 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1593077420 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1593077422 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Polymerase proofreading-related adenomatous polyposis |
| RS1593077673 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1593078223 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593078531 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1593079711 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1593080925 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593082154 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593082215 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593083585 |
RAD9B
|
Health Risk |
Likely pathogenic |
Neural tube defect, Neural tube defect |
| RS1593086031 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593086474 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593087229 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593088347 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Intrauterine growth retardation |
| RS1593088395 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593090725 |
SOX5
|
Health Risk |
Pathogenic |
Lamb-Shaffer syndrome, Lamb-Shaffer syndrome |
| RS1593099111 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593107841 |
NCOR2
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1593114820 |
NR1H4
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1593121484 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1593121507 |
SACS
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593121924 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1593123432 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1593124372 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1593125290 |
SACS
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593125341 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593129673 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1593133306 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1593133395 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |